EVOGENE LTDNARY SHARES
EVOGENE LTDNARY SHARES
Acción · IL0011050551 · EVGN (XNAS)
Resumen Indicadores financieros
1,10 USD
-0,45 % -0,005 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
06.06.2025 19:55

Cotizaciones actuales de EVOGENE LTDNARY SHARES

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
EVGN
USD
06.06.2025 19:55
1,10 USD
1,11 USD
-0,45 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 0,92 % -3,51 % -22,54 % -23,08 % -83,82 % -90,91 %

Firmenprofil zu EVOGENE LTDNARY SHARES Aktie

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Unternehmensdaten

Name EVOGENE LTDNARY SHARES
Firma Evogene Ltd.
Symbol EVGN
Website https://www.evogene.com
Heimatbörse XNAS NASDAQ
ISIN IL0011050551
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Ofer Haviv CPA
Land Israel
Währung USD
Mitarbeiter 0,1 T
Adresse 13 Gad Feinstein Street, 7414002 Rehovot
IPO Datum 2010-10-15

Aktien-Splits

Datum Split
25.07.2024 1:10
19.11.2013 1:2

Ticker Symbole

Name Symbol
NASDAQ EVGN

Weitere Aktien

Investoren die EVOGENE LTDNARY SHARES die halten, haben auch folgende Aktien im Depot:
AMUNDI INDEX MSCI EMERGING MARKETS IE - EXF (D)
AMUNDI INDEX MSCI EMERGING MARKETS IE - EXF (D) ETF
DHT S INCNEW
DHT S INCNEW Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025